[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@bio_report BioReport

BioReport posts on X about $mygn, $exas, $meta, $srpt the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

• X Week XXXXX -XX%
• X Month XXXXXX -XXXX%
• X Months XXXXXXX -XX%
• X Year XXXXXXX +45%

Mentions: X #

• X Week X -XX%
• X Month XXX +191%
• X Months XXX -XX%
• X Year XXX +5.80%

Followers: XXXXX #

• X Week XXXXX +1.40%
• X Month XXXXX +4.80%
• X Months XXXXX +14%
• X Year XXXXX +60%

CreatorRank: undefined #

Social Influence

Social category influence finance XXXXX% stocks XXXXX% cryptocurrencies XXXXX% technology brands XXXXX%

Social topic influence $mygn #2, $exas 33.33%, $meta 22.22%, $srpt #27, $capr #36, meta 22.22%, $gh 22.22%, $lmt 11.11%, stocks 11.11%, $czr XXXXX%

Top accounts mentioned or mentioned by @martinshkreli @anthonystaj @venu7

Top assets mentioned Exact Sciences Corp (EXAS) Metadium (META) Sarepta Therapeutics, Inc. (SRPT) Guardant Health, Inc. Common Stock (GH) Limitus (LMT) Caesars Entertainment, Inc. (CZR) Club Atletico Independiente Fan Token (CAI)

Top Social Posts

Top posts by engagements in the last XX hours

"$MYGN if shares are really down on competing prostate cancer test then youre not following the stock closely. Revenue for that test is immaterial"
X Link 2025-12-01T19:01Z 1236 followers, XXX engagements

"Stocks way undervalued; - $MYGN -$LMT -$META -$SRPT -$CAPR -$CZR"
X Link 2025-12-02T15:44Z 1236 followers, XXX engagements

"$MYGN is the only hereditary cancer company left to buy. Would expect $GH or $EXAS to buy it at some point as they are trying to launch their own tests but will have little success"
X Link 2025-10-30T13:56Z 1235 followers, XXX engagements

"$MYGN all analysts increasing price targets following earnings and stock down 20%. Makes zero sense:"
X Link 2025-11-04T19:18Z 1235 followers, XXX engagements

"Pretty shocking that $MYGN does not trade with an acquisition premium. Its the only buyable company with any significant hereditary cancer business in a space all the big somatic players want to enter. Its also one of the few money making diagnostic tests $CAI $EXAS $GH"
X Link 2025-11-11T15:31Z 1235 followers, XXX engagements

"$MYGN should be up BIG. The $EXAS deal shows how undervalued they are"
X Link 2025-11-20T18:38Z 1235 followers, XXX engagements

"@Venu_7_ $MYGN or $META"
X Link 2025-11-23T15:27Z 1235 followers, XXX engagements

"Maybe $CAPR should buy $SRPT"
X Link 2025-12-03T15:45Z 1235 followers, 1277 engagements